Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Divae OD** is an oral alpha-ketoanalogue tablet product listed by Saltvae Pharmaceuticals. Alpha-ketoanalogues are nitrogen-free precursors of essential amino acids used with protein-restricted dietary management in chronic kidney disease to support protein nutrition while limiting nitrogenous waste generation. The public product listing identifies the product as \"DIVAE OD 500\" and as alpha-ketoanalogue tablets, but does not disclose its precise ingredient composition, regulatory approval status, or clinical-development history. ([indiamart.com](https://www.indiamart.com/saltvae-pharmaceuticals-private-limited/))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Divae OD.